Bioavailability and Pharmacodynamics of EPA and DHA From Fortified Soymilk and Capsules
Clinical trial NCT05802797 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05802797
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-03
- Primary completion
- 2026-07-10
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.